from application on site with lack of cleanlinessresultingfrom application on site with lack of cleanliness
to more complications and higher hospitalization ratesleadsto more complications and higher hospitalization rates
hospitalization and increases the economic burden of diabetic patientleadshospitalization and increases the economic burden of diabetic patient
30 % to 50 % of treatment failures and 125,000 deaths per year in the US among patients diagnosed with a chronic diseasecauses30 % to 50 % of treatment failures and 125,000 deaths per year in the US among patients diagnosed with a chronic disease
to drug - resistant strains of HIV , which are not only associated with increased mortality in patients [ 12 , 13 ] but also can be transmitted to others [ 14 , 15also contributesto drug - resistant strains of HIV , which are not only associated with increased mortality in patients [ 12 , 13 ] but also can be transmitted to others [ 14 , 15
in lowered vaccine efficacymay resultin lowered vaccine efficacy
to failure of HIV drug trials ( 3/4 ) FasterCuresleadsto failure of HIV drug trials ( 3/4 ) FasterCures
to treatment failure , viral resistance , and related infectionsinvariably leadsto treatment failure , viral resistance , and related infections
to antibiotic resistant strainshas leadto antibiotic resistant strains
drug resistance to developcan causedrug resistance to develop
in failure to prevent viral replication as well as an increased risk of developing drug resistancewould resultin failure to prevent viral replication as well as an increased risk of developing drug resistance
usuallyleadsusually
to HIV drug resistanceleadsto HIV drug resistance
to drug resistance and drug failurecould leadto drug resistance and drug failure
to less than optimal treatment outcomes , which in turn leads to increases in illness , hospital admissions , mortality , and overall healthcare costsleadsto less than optimal treatment outcomes , which in turn leads to increases in illness , hospital admissions , mortality , and overall healthcare costs
in the development of drug resistance and poor virologic outcomesmay resultin the development of drug resistance and poor virologic outcomes
to a situation where your tablets are no longer managing your HIV effectivelymay leadto a situation where your tablets are no longer managing your HIV effectively
huge financial lossescauseshuge financial losses
to problems with resistance to the medicationleadsto problems with resistance to the medication
this form of drug resistance(passive) is ... caused bythis form of drug resistance
to inadequate glycaemic control , which in turn increases the risk of diabetic complications and mortality.7leadsto inadequate glycaemic control , which in turn increases the risk of diabetic complications and mortality.7
from issues surrounding cosmetic acceptability , which leads to loss of effect and patient dissatisfaction with the treatmentcan resultfrom issues surrounding cosmetic acceptability , which leads to loss of effect and patient dissatisfaction with the treatment
in treatment failure , resistance to treatment , and increased mortalityresultedin treatment failure , resistance to treatment , and increased mortality
to reduced rates of responseleadsto reduced rates of response
to the virologic failure of patients using cheaper first - line treatment regimens and the spread of drug resistant forms of the viruscan leadto the virologic failure of patients using cheaper first - line treatment regimens and the spread of drug resistant forms of the virus
to the emergence of drug resistant strains of the virus and transmission during risky behaviorscan contributeto the emergence of drug resistant strains of the virus and transmission during risky behaviors
to reduced clinical benefit , a raised incidence of secondary complicationsleadsto reduced clinical benefit , a raised incidence of secondary complications
in peeling or flakingresultingin peeling or flaking
to unsuppressed virus , more advanced HIV disease and poorer health outcomescan leadto unsuppressed virus , more advanced HIV disease and poorer health outcomes
treatment failure , complications and the development of drug resistanceresultingtreatment failure , complications and the development of drug resistance
in worsening of the condition , death , and increases in the cost of health carecan resultin worsening of the condition , death , and increases in the cost of health care
in unnecessary disease progression , treatment complications , reduced functional abilities , lower quality of life , and premature death.39can resultin unnecessary disease progression , treatment complications , reduced functional abilities , lower quality of life , and premature death.39
to ongoing replication of HIV and subsequent loss of CD4 lymphocytescan also leadto ongoing replication of HIV and subsequent loss of CD4 lymphocytes
in poor outcomeswill often resultin poor outcomes
in poor productalmost invariably resultsin poor product
to treatment - limiting drug resistancecan leadto treatment - limiting drug resistance
to worsening of diseaseleadsto worsening of disease
to ] troublesome symptoms , time off work and treatment in hospitalcan leadto ] troublesome symptoms , time off work and treatment in hospital